LG Chem, Ltd.
Seoul, Korea, Republic of
Purpose
to fund development of the new DTwP-HepB-Hib-IPV hexavalent vaccine in order to supply to GAVI countries at an affordable price.
Division
Global Health
Date
March 2019
Region Served
GLOBAL
Committed amount
$26,176,033
Grant topic
Vaccine Development
Duration (months)
71
Grantee location
Seoul, Korea, Republic of
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.